[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precision Biosciences Inc (DTIL)

Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 211,576
  • Shares Outstanding, K 25,802
  • Annual Sales, $ 34,260 K
  • Annual Income, $ -45,720 K
  • EBIT $ -39 M
  • EBITDA $ -37 M
  • 60-Month Beta 1.31
  • Price/Sales 5.92
  • Price/Cash Flow N/A
  • Price/Book 2.61

Options Overview Details

View History
  • Implied Volatility 236.68% (-27.53%)
  • Historical Volatility 59.52%
  • IV Percentile 24%
  • IV Rank 16.60%
  • IV High 1,350.68% on 03/11/26
  • IV Low 14.92% on 12/16/25
  • Expected Move (DTE 2) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 39
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 1,211
  • Open Int (30-Day) 1,307
  • Expected Range 8.20 to 8.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.49
  • Number of Estimates 1
  • High Estimate $-0.49
  • Low Estimate $-0.49
  • Prior Year $-2.13
  • Growth Rate Est. (year over year) +77.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.50 +26.15%
on 05/05/26
8.25 -0.61%
on 05/12/26
+1.53 (+22.94%)
since 04/10/26
3-Month
3.69 +122.22%
on 02/19/26
8.25 -0.61%
on 05/12/26
+4.24 (+107.07%)
since 02/12/26
52-Week
3.53 +132.29%
on 02/05/26
8.82 -7.03%
on 10/29/25
+2.98 (+57.09%)
since 05/12/25

Most Recent Stories

More News
Precision BioSciences: Q1 Earnings Snapshot

Precision BioSciences: Q1 Earnings Snapshot

DTIL : 8.20 (+4.33%)
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update

- Continued advancement of the Phase 1/2a ELIMINATE-B trial of PBGENE-HBV across multiple dosing cohorts; Late-Breaking poster presentation for PBGENE-HBV accepted at European Association...

TGTX : 42.54 (-1.39%)
DTIL : 8.20 (+4.33%)
Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet...

DTIL : 8.20 (+4.33%)
Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study

- Arkansas Children’s Hospital activated as the first clinical trial site and now enrolling patients in the FUNCTION-DMD study of PBGENE-DMD -

DTIL : 8.20 (+4.33%)
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet...

DTIL : 8.20 (+4.33%)
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies...

DTIL : 8.20 (+4.33%)
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026

- Late-breaking poster presentation to highlight new biopsy data demonstrating elimination and inactivation of cccDNA from the ongoing Phase 1 ELIMINATE-B trial in chronic hepatitis B -...

DTIL : 8.20 (+4.33%)
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries

- France and Romania planned for inclusion in the global ELIMINATE-B trial supporting broader patient enrollment -

DTIL : 8.20 (+4.33%)
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet...

DTIL : 8.20 (+4.33%)
Precision BioSciences: Q4 Earnings Snapshot

Precision BioSciences: Q4 Earnings Snapshot

DTIL : 8.20 (+4.33%)

Business Summary

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

See More

Key Turning Points

3rd Resistance Point 9.20
2nd Resistance Point 8.73
1st Resistance Point 8.46
Last Price 8.20
1st Support Level 7.72
2nd Support Level 7.25
3rd Support Level 6.98

See More

52-Week High 8.82
Last Price 8.20
Fibonacci 61.8% 6.80
Fibonacci 50% 6.17
Fibonacci 38.2% 5.55
52-Week Low 3.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.